Search Results - "Sumitomo M"

The effects of fluid inertia forces on the dynamic behavior of short journal bearings in superlaminar flow regime.

Authors: Hashimoto, H. Wada, S. Sumitomo, M.

Source: Journal of Tribology; July 1988, Vol. 110, p539-545, 7p

Nature of oil-burn on steel surfaces.

Authors: Tamai, Y. Sumitomo, M.

Source: Lubrication Engineering; February 1975, Vol. 31, p81-83, 3p

Overexpression of IL-1ra gene up-regulates interleukin-1β converting enzyme (ICE) gene expression: possible mechanism underlying IL-1β-resistance of cancer cells.

Authors: Sumitomo, M Tachibana, M Murai, M et al.

Source: British Journal of Cancer. 9/15/99, Vol. 81 Issue 2, p277. 10p.

This result is not displayed to guests.
Login for full access.

P167 - Targeting glutamine addiction to induce ferroptosis with potent drug combination therapy for renal cell carcinoma.

Authors: Takeuchi, A. Sumitomo, M. Yoshimura, A. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS234-S234. 1p.

A0374 - Evaluation of copy number and allelic imbalance of BRCA2 by next-generation sequencing to predict prognosis and drug sensitivity in prostate cancer.

Authors: Sumitomo, M. Nukaya, T. Sugihara, E. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS542-S542. 1p.

54 - Targeting lactate dehydrogenase-A promotes docetaxel induced cytotoxicity predominantly in castration-resistant prostate cancer cells.

Authors: Muramatsu, H. Sumitomo, M. Sugie, M. et al.

Source: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe81-e81. 1p.

733 ENHANCED TRANSACTIVATION OF THE EGFR-ERK1/2 CELL SURVIVAL PATHWAY UNDER HYPOXIA CONFERS RESISTANCE TO RAPAMYCIN AND COULD BE A THERAPEUTIC TARGET IN RENAL CELL CARCINOMA

Authors: Sumitomo, M. Asano, T. Sato, A. et al.

Source: European Urology Supplements. Mar2011, Vol. 10 Issue 2, p233-234. 2p.

205 Transactivation of the EGFR cell survival pathway under hypoxia mediates mTOR activation and induction of HIF-α proteins and resistance to rapamycin especially in wild-type VHL renal cell carcinoma

Authors: Sumitomo, M. Asano, T. Nakamura, K. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe205-e205. 1p.

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Authors: Horiguchi, A. Asano, T. Kuroda, K. et al.

Source: British Journal of Cancer. 5/25/2010, Vol. 102 Issue 11, p1592-1599. 8p. 5 Graphs.

P101 - The impact of exposure to ileal feces during intracorporeal urinary diversion: Cultivable microbiota of the distal ileum.

Authors: Zennami, K. Nukaya, T. Ishikawa, K. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS137-S138. 2p.

Immobilization of fly ash from MSW incinerators and ash-melting furnaces

Authors: Kawakami, I. Esaki, M. Sumitomo, M. et al.

Source: Waste Management. 1996, Vol. 16 Issue 5/6, p483. 0p.

Subjects: Incineration, Waste treatment

New microsurgical technique for intraparenchymal lesions of the brain: transcylinder approach.

Authors: Ogura, K. Tachibana, E. Aoshima, C. et al.

Source: Acta Neurochirurgica. Jul2006, Vol. 148 Issue 7, p779-785. 7p. 3 Black and White Photographs, 2 Diagrams, 1 Chart.

Effects of barbiturates on ATP-sensitive K channels in rat substantia nigra

Authors: Ohtsuka, T. Ishiwa, D. Kamiya, Y. et al.

Source: Neuroscience. Mar2006, Vol. 137 Issue 2, p573-581. 9p.

A1043 - Targeting glutamine addiction with potent drug combination therapy for renal cell carcinoma.

Authors: Muto, Y. Takeuchi, A. Zennami, K. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1507-S1507. 1p.

A1041 - Comprehensive analysis of copy number variation and sensitivity to targeted therapy in renal cell carcinoma using in-house cancer gene panel testing.

Authors: Takeuchi, A. Takeda, M. Sugihara, E. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1504-S1504. 1p.

46 - Loss of miR-21 delays Myc-driven prostate cancer progression in the Hi-Myc transgenic mouse model.

Authors: Zennami, K. Rafiqi, F. Liao, R. et al.

Source: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe62-e63. 2p.

40 Determination of doripenem penetration into human prostate tissue

Authors: Nakamura, K. Ikawa, K. Yamada, Y. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe40-e40a. 2p.

166 - Should Gleason score at the positive surgical margin site be reported on the pathology report of robot-assisted radical prostatectomy?

Authors: Kanao, K. Sugie, M. Muramatsu, H. et al.

Source: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe246-e246. 1p.

840 Can small lesions of Gleason 3+4 be left untreated in focal therapy? Analysis of radical prostatectomy specimens.

Authors: Kanao, K. Kajikawa, K. Kobayashi, I. et al.

Source: European Urology Supplements. Mar2016, Vol. 15 Issue 3, pe840-e840. 1p.